FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

1636411000168101: cannabidiol 100 mg / 1 mL + delta-9-tetrahydrocannabinol 3.3 mg / 1 mL oral liquid, 30 mL (medicinal product pack)

Status: current, Defined. Date: 30-Nov 2022. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4758271000168111 cannabidiol 100 mg / 1 mL + delta-9-tetrahydrocannabinol 3.3 mg / 1 mL oral liquid, 30 mL (medicinal product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4758281000168114 delta-9-tetrahydrocannabinol 3.3 mg/mL + cannabidiol 100 mg/mL oral liquid, 30 mL en Synonym Active Case sensitive Australian Medicines Terminology module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
delta-9-tetrahydrocannabinol 3.3 mg/mL + cannabidiol 100 mg/mL oral liquid, 30 mL Is a medicinal product pack false Inferred relationship Some
delta-9-tetrahydrocannabinol 3.3 mg/mL + cannabidiol 100 mg/mL oral liquid, 30 mL has MPUU delta-9-tetrahydrocannabinol 3.3 mg/mL + cannabidiol 100 mg/mL oral liquid true Inferred relationship Some 444617170
delta-9-tetrahydrocannabinol 3.3 mg/mL + cannabidiol 100 mg/mL oral liquid, 30 mL Is a cannabidiol 100 mg/mL oral liquid, 30 mL true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Mercury Pharma MP 1:30 (THC 3.3:CBD 100) oral liquid, 30 mL Is a True delta-9-tetrahydrocannabinol 3.3 mg/mL + cannabidiol 100 mg/mL oral liquid, 30 mL Inferred relationship Some

Reference Sets

Schedule 8 medications reference set

Medicinal product pack reference set

Back to Start